应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
SILO SILO PHARMA INC.
交易中 09-08 15:02:56 EDT
2.26
-0.14
-5.83%
最高
2.36
最低
2.26
成交量
1.33万
今开
2.33
昨收
2.40
日振幅
3.99%
总市值
358.96万
流通市值
344.31万
总股本
158.83万
成交额
3.09万
换手率
0.87%
流通股本
152.35万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Silo Pharma与Parkview Consulting签署资产购买协议，2026年8月18日SEC文件披露
美股速递 · 08-20
Silo Pharma与Parkview Consulting签署资产购买协议，2026年8月18日SEC文件披露
Silo Pharma：根据SEC文件，出售股东以转售方式提供190万股Silo Pharma普通股
美股速递 · 07-25
Silo Pharma：根据SEC文件，出售股东以转售方式提供190万股Silo Pharma普通股
Silo Pharma子公司Qwikagents拟通过英伟达开发者计划推进企业AI智能体平台发展
美股速递 · 07-07
Silo Pharma子公司Qwikagents拟通过英伟达开发者计划推进企业AI智能体平台发展
Silo Pharma 开展稳健性研究，评估 SPC-15 设备性能与制剂 30 天稳定性
美股速递 · 06-30
Silo Pharma 开展稳健性研究，评估 SPC-15 设备性能与制剂 30 天稳定性
Silo Pharma公布SPC-15创伤后应激障碍治疗药物稳定性数据积极，推动项目迈向首次人体临床试验
美股速递 · 06-23
Silo Pharma公布SPC-15创伤后应激障碍治疗药物稳定性数据积极，推动项目迈向首次人体临床试验
Silo Pharma旗下Demerx NB获FDA新药临床试验批准 诺伊波加因靶向酒精使用障碍治疗
美股速递 · 04-29
Silo Pharma旗下Demerx NB获FDA新药临床试验批准 诺伊波加因靶向酒精使用障碍治疗
Silo制药公司战略性收购Qwikagents平台 进军千亿美元AI代理市场
美股速递 · 04-23
Silo制药公司战略性收购Qwikagents平台 进军千亿美元AI代理市场
Silo Pharma, Inc.盘中异动 股价大跌5.46%报1.28美元
市场透视 · 2025-03-03
Silo Pharma, Inc.盘中异动 股价大跌5.46%报1.28美元
Silo Pharma, Inc.盘中异动 股价大跌5.67%
市场透视 · 2025-02-27
Silo Pharma, Inc.盘中异动 股价大跌5.67%
Silo Pharma, Inc.盘中异动 快速上涨5.40%报1.47美元
市场透视 · 2025-02-27
Silo Pharma, Inc.盘中异动 快速上涨5.40%报1.47美元
Silo Pharma, Inc.盘中异动 急速拉升5.56%报1.38美元
市场透视 · 2025-02-26
Silo Pharma, Inc.盘中异动 急速拉升5.56%报1.38美元
Silo Pharma, Inc.盘中异动 早盘股价大跌5.19%报1.28美元
市场透视 · 2025-02-24
Silo Pharma, Inc.盘中异动 早盘股价大跌5.19%报1.28美元
Silo Pharma, Inc.盘中异动 下午盘急速下跌5.03%报1.42美元
市场透视 · 2025-02-22
Silo Pharma, Inc.盘中异动 下午盘急速下跌5.03%报1.42美元
Silo Pharma, Inc.盘中异动 快速拉升5.00%报1.47美元
市场透视 · 2025-02-20
Silo Pharma, Inc.盘中异动 快速拉升5.00%报1.47美元
Silo Pharma, Inc.盘中异动 早盘大幅下跌5.19%
市场透视 · 2025-02-11
Silo Pharma, Inc.盘中异动 早盘大幅下跌5.19%
Silo Pharma, Inc.盘中异动 早盘快速拉升5.68%报1.82美元
市场透视 · 2025-02-06
Silo Pharma, Inc.盘中异动 早盘快速拉升5.68%报1.82美元
Silo Pharma, Inc.盘中异动 股价大跌5.02%
市场透视 · 2025-02-04
Silo Pharma, Inc.盘中异动 股价大跌5.02%
Silo Pharma, Inc.盘中异动 大幅上涨11.19%报1.79美元
市场透视 · 2025-02-03
Silo Pharma, Inc.盘中异动 大幅上涨11.19%报1.79美元
Silo Pharma, Inc.盘中异动 大幅跳水5.46%
市场透视 · 2025-02-01
Silo Pharma, Inc.盘中异动 大幅跳水5.46%
Silo Pharma, Inc.盘中异动 下午盘大幅下跌5.07%
市场透视 · 2025-01-28
Silo Pharma, Inc.盘中异动 下午盘大幅下跌5.07%
加载更多
公司概况
公司名称：
SILO PHARMA INC.
所属市场：
NASDAQ
上市日期：
--
主营业务：
Silo Pharma, Inc.于2010年7月13日在纽约州注册成立。2013年1月24日，公司将其注册地从纽约州改为特拉华州。2023年12月19日，该公司将其注册州从特拉华州改为内华达州。该公司是一家处于开发阶段的生物制药和加密货币公司，专注于开发针对创伤后应激障碍、应激性焦虑症、纤维肌痛和中枢神经系统疾病等未满足需求的新型疗法。其主要项目SPC-15是一种用于治疗创伤后应激障碍和应激性焦虑症的鼻内候选药物。
发行价格：
--
{"stockData":{"symbol":"SILO","market":"US","secType":"STK","nameCN":"SILO PHARMA INC.","latestPrice":2.26,"timestamp":1788893930540,"preClose":2.4,"halted":0,"volume":13316,"delay":0,"changeRate":-0.05833333333333339,"floatShares":1523502,"shares":1588300,"eps":-5.066727,"marketStatus":"交易中","change":-0.14,"latestTime":"09-08 15:02:56 EDT","open":2.33,"high":2.3557,"low":2.26,"amount":30886.3727828,"amplitude":0.039875,"askPrice":2.31,"askSize":106,"bidPrice":2.21,"bidSize":1299,"shortable":0,"etf":0,"ttmEps":-5.066727,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1788897600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":2.4,"postHourTrading":{"tag":"盘后","latestPrice":2.4,"preClose":2.4,"latestTime":"19:39 EDT","volume":26,"amount":59.28,"timestamp":1788565143263,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.899249},"requestUrl":"/m/hq/s/SILO","defaultTab":"news","newsList":[{"id":"1125334791","title":"Silo Pharma与Parkview Consulting签署资产购买协议，2026年8月18日SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1125334791","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125334791?lang=zh_cn&edition=full","pubTime":"2026-08-20 05:19","pubTimestamp":1787174351,"startTime":"0","endTime":"0","summary":"Silo Pharma于2026年8月18日与Parkview Consulting达成资产购买协议。此消息源自公司向美国证券交易委员会（SEC）提交的官方文件。\n这一战略举措标志着Silo Pharma在业务布局上的重要一步。协议签署的细节已在监管文件中完整呈现。\n市场参与者对此交易的反应尚待观察。Silo Pharma的这一决策，可能预示着公司在资产组合优化方面的新动向。SEC文件为该协议的条款提供了正式记录，确保交易的透明度。\n截至发稿时，Silo Pharma尚未就协议的具体财务条款和涉及的资产类别发表进一步评论。此次合作或将影响公司未来的发展方向，值得持续关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SILO","BK4202","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168075273","title":"Silo Pharma：根据SEC文件，出售股东以转售方式提供190万股Silo Pharma普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1168075273","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168075273?lang=zh_cn&edition=full","pubTime":"2026-07-25 04:08","pubTimestamp":1784923689,"startTime":"0","endTime":"0","summary":"Silo Pharma（SILO）传来最新消息——据美国证券交易委员会（SEC）披露的文件显示，该公司的出售股东正计划以转售方式，将高达190万股Silo Pharma普通股推向市场。这一动作并非由公司直接增发，而是现有股东在特定条件下进行股份转让或流通。这一规模不容小觑，可能对市场供需格局产生一定影响。交易细节与背景仍需投资者持续关注，以评估后续的市场反应与股价走向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SILO","BK4202","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142669587","title":"Silo Pharma子公司Qwikagents拟通过英伟达开发者计划推进企业AI智能体平台发展","url":"https://stock-news.laohu8.com/highlight/detail?id=1142669587","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142669587?lang=zh_cn&edition=full","pubTime":"2026-07-07 20:16","pubTimestamp":1783426561,"startTime":"0","endTime":"0","summary":"Silo Pharma旗下子公司Qwikagents正着手通过参与英伟达开发者计划，以加速其企业级人工智能智能体平台的研发进程。此举旨在利用英伟达先进的硬件与软件生态系统，赋能其AI解决方案，从而在竞争激烈的企业服务市场中占据更有利的技术高地。通过接入该计划，Qwikagents将能够更深入地整合英伟达的计算平台与开发工具，这有望显著提升其AI智能体在处理复杂企业任务时的性能与效率。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0124676726.USD","LU2290526834.HKD","LU1267930573.SGD","IE00BMPRXN33.USD","LU1992135399.USD","NVII","BK4202","LU1551013342.USD","IE00BK4W5M84.HKD","SMHX","LU1791710400.SGD","LU1674673428.USD","LU0640476718.USD","IE00B775H168.HKD","CLSE","LU2403377893.USD","LU0708994859.HKD","SG9999015986.USD","LU1712237335.SGD","BK4141","LU0061474960.USD","LU2357125470.USD","LU1951198990.SGD","LU2168563687.JPY","LU0056508442.USD","LU1119994496.HKD","LU0198837287.USD","ANV","LU1988902786.USD","IE00B5949003.HKD","FAI","BK4585","LU0861579265.USD","BK4551","LU0672654240.SGD","BK4534","LU0689472784.USD","SG9999018865.SGD","IE00B19Z9505.USD","LU2413666699.HKD","LU1116320901.HKD","LU1400636574.HKD","SOXQ","CNEQ","BK4532","LU2505996509.AUD","LU0786609619.USD","LU1633808545.USD","LU2756315664.SGD","LU1202635105.USD","LU2125909759.SGD","LU1934455863.HKD","LU2023250330.USD","LU1267930490.SGD","2NVD.UK","LU1066051225.USD","BK4579","LU0109391861.USD","LU2746668974.SGD","NVDD","LU2242650005.HKD","HK0000306701.USD","SGXZ31699556.SGD","IE00BHPRN162.USD","LU0006306889.USD","LU1035775433.USD","LU1868836914.USD","NVDU","ROM","LU1496350171.SGD","LU0472753341.HKD","LU0557290698.USD","LU0345770993.USD","LU2237443895.HKD","LU1720051108.HKD","BK4592","LU2552382215.SGD","LU2148611432.USD","LU0353189680.USD","LU0942090050.USD","LU2471134879.HKD","SNVD.UK","LU0175139822.USD","LU0345769631.USD","LU1116320737.USD","LU1699723380.USD","IE00BMPRXQ63.HKD","LU2552382058.USD","IE0001KFT4U8.USD","LU1868837300.USD","LU1400636657.SGD","USXF","LU1815333072.USD","LU0251132253.USD","SGXZ23171101.USD","LU0823434740.USD","LU1244550221.USD","LU1429558221.USD","LU0094547139.USD","IXN","LU0289739343.SGD","LU1066051811.HKD","LU1232071149.USD","LU0080751232.USD","IE00BKDWB100.SGD","LU2360107168.USD","HK0000914686.HKD","LU0048584097.USD","LU1868836757.USD","TYLG","LU2637965513.SGD","IE0004445015.USD","LU1066053197.SGD","LU2326559502.SGD","LU1435385759.SGD","LU1880398471.USD","LU0157215616.USD","LU0096362180.USD","LU1280957306.USD","LU0868494617.USD","IE00B1BXHZ80.USD","LU2083900584.USD","LU2125909593.SGD","LU0823414551.USD","SG9999002232.USD","LU1852331112.SGD","BK4550","LU2237438978.USD","LU2487616109.SGD","LU2357305700.SGD","LU0138981039.USD","LU0158827781.USD","SG9999000418.SGD","LU0390134368.USD","LU0082616367.USD","LU2954938101.SGD","XLK","NVDA","SG9999014575.USD","LU2244417387.USD","LU2458330169.SGD","LU0957808578.USD","LU2065171402.SGD","WISE","LU0096364046.USD","LU0964807845.USD","LU1366192091.USD","IE00BD6J9T35.USD","LU0528227936.USD","07388","SG9999017495.SGD","LU2168564149.EUR","LU0170899867.USD","IE00BYXW3230.USD","LU0265550946.USD","HK0000914660.USD","BK4605","LU2077746001.SGD","NVDS","NVDW","LU1642822529.SGD","LU0965509101.SGD","LU2272731865.HKD","LU2106854487.HKD","SG9999014914.USD","LU1267930730.SGD","LU1721428933.USD","BK4139","LU1153585028.USD","LU2125154778.USD","LU1914381329.SGD","LU2471134952.CNY","LU1989772923.USD","LU0308772762.SGD","LU1935042488.USD","LU0215105999.USD","LU2394011477.USD","HK0000320223.HKD","IE000W1ABFV2.USD","LU1992135472.HKD","LU0011850046.USD","LU2092627202.USD","LU2602419157.SGD","NVDL","LU2491050071.SGD","LU2360106780.USD","LU2433249047.HKD","LU2250418816.HKD","LU2271345857.HKD","LU0323239441.USD","LU2417539215.USD","IE0034235295.USD","LU1548497426.USD","LU1242518931.SGD","SG9999018857.SGD","LU2111349929.HKD","IE00BMPRXR70.SGD","SNPE","VGT","IE00BJTD4V19.USD","LU2089985449.USD","SG9999004303.SGD","LU0788109477.HKD","FTEC","BK4581","LU0466842654.USD","LU0061475181.USD","AGOX","LU1037948541.HKD","LU0211327993.USD","LU0057025933.USD","LU0417517546.SGD","LU2237443382.USD","LU2430703251.USD","LU2065169927.USD","LU0029864427.USD","SG9999014898.SGD","NVYY","LU0354030511.USD","LU1983260115.SGD","IE00BJTD4N35.SGD","LU2097344357.USD","IE00BKVL7J92.USD","LU2471134796.USD","LU2168564222.USD","LU1674673691.USD","SG9999014906.USD","LU1861127337.USD","LU1803068979.SGD","LU1366333091.USD","LU1069344957.HKD","SG9999015978.USD","LU0143551892.USD","LU0708995401.HKD","LU2592432038.USD","BK4548","LU0289961442.SGD","LU0053666078.USD","LU2237957811.SGD","LU1935043536.SGD","LU0081259029.USD","LU0061474705.USD","SG9999015952.SGD","IE00B19Z8X17.USD","SOXY","LU2100268510.USD","LU1923623000.USD","LU0234570918.USD","IE00BK4W5L77.USD","LU2463028550.USD","LU2506951792.HKD","IE00BZ1G4Q59.USD","LU0154236417.USD","EFIV","HK0000304797.USD","ESUM","LU1804176565.USD","LU1623119135.USD","IE00B19Z8W00.USD","LU1778281490.HKD","CHAT","LU1718418525.SGD","LU1571399168.USD","LU0957791311.USD","LU0158827948.USD","LU1974910355.USD","LU1496350502.SGD","LU0348723411.USD","NVD2.UK","IE0003U64NQ7.SGD","LU2458330243.SGD","LU0882574139.USD","LU0353189763.USD","BK4543","LU2023251221.USD","IE0004091025.USD","SG9999015358.SGD","LU0097036916.USD","LU1951200564.SGD","LU2063271972.USD","LU2456880835.USD","IE00BKPKM429.USD","LU1064131342.USD","LU2213496289.HKD","IE00BDCRKT87.USD","LU1821325948.USD","METV","SG9999002224.SGD","ABFL","LU2247934214.USD","LU2999663052.SGD","IE00B1XK9C88.USD","LU2543165471.USD","LU1989772840.SGD","LU2322448791.USD","LU2452424414.USD","LU0889565833.HKD","LU2746668461.USD","IE000KEQY171.SGD","IE00BJJMRY28.SGD","SG9999014880.SGD","LU2931357623.SGD","HK0000320264.USD","LU2191332357.HKD","IE00B7KXQ091.USD","JGRO","LU2413666426.HKD","LU1145028129.USD","LU2237443978.SGD","LU1989764664.SGD","IE0034235303.USD","LU0106261372.USD","DIPS","LU2028103732.USD","LU1691799644.USD","BK4588","LU0985320562.USD","LU2108987350.USD","LU1880398554.USD","BK4587","IE00B775SV38.USD","LU0234572021.USD","IE00BJLML261.HKD","07788","LU1244550577.SGD","NVDO","LU1037948897.HKD","LU1066051498.USD","LU0210528500.USD","SG9999001424.SGD","LU1316542783.SGD","NVD3.UK","SPTE","SG9999014567.USD","IE00BFSS8Q28.SGD","SGXZ51526630.SGD","NVDQ","LU2322448957.HKD","LU2264538146.SGD","TRFK","LU0476273544.USD","LU0345770308.USD","LU2430703095.HKD","HK0000532082.HKD","LU0316494557.USD","LU2249611893.SGD","IE00B3M56506.USD","IE00B3S45H60.SGD","LU1839511570.USD","LU0265550359.USD","IE0004086264.USD","IE00BJJMRX11.SGD","LU2381873111.SGD","LU0719512351.SGD","LU0345769128.USD","LU2125909247.SGD","ILDR","LU2211815571.USD","LU2125154935.USD","LU2491049909.HKD","LU0238689110.USD","LU0077335932.USD","LU2420271590.USD","IE00BDRTCR15.USD","LU2272731600.USD","LU0127658192.USD","LU2462591277.SGD","LU1923622614.USD","LU0323240290.USD","LU2092937148.SGD","LU0943347566.SGD","LU0345768740.USD","LU0109392836.USD","BK4614","LU0187121727.USD","LU0323591593.USD","USD","SOXX","LU2097344431.USD","LU1400636491.USD","LU2065170008.USD","LU1935043023.USD","LU1989764748.USD","LU0320765059.SGD","LU0107464264.USD","LU0444971666.USD","SHOC","LU0724617625.USD","LU2237443622.USD","IE0009G5SDU7.USD","LU2294711713.HKD","HK0000306685.HKD","LU0203201768.USD","LU2054465674.USD","LU2430703178.SGD","LU1814569148.SGD","LU2750360997.AUD","LU2286300806.USD","LU0823414478.USD","BK4598","TEK","SG9999014542.SGD","LU2462591350.SGD","LU0128525929.USD","LU1861220033.SGD","FDTX","LU1244550494.USD","LU0079474960.USD","ARTY","LU1868836591.USD","BK4567","LU1791710582.SGD","VT","LU0174119429.USD","AIPI","LU1720051017.SGD","LU1323610961.USD","LU1629891620.HKD","LU0965509010.AUD","IETC","LU0444973449.USD","LU2089283258.USD","LU2242649171.HKD","LU1861215975.USD","LU0310800379.SGD","LU1645745479.HKD","LU1670756490.USD","IE00BZ199S13.USD","NVDB","IE00BWXC8680.SGD","BK4612","LU2168564495.EUR","LU2471134523.USD","IE00B4YYXB79.USD","SGXZ81514606.USD","LU0787776722.HKD","IE0005OL40V9.USD","LU2023250504.SGD","LU2473716301.USD","LU2089284900.SGD","TTEQ","LU2361045086.USD","LU0689626769.HKD","LU2065171311.SGD","BK4503","IE00BN29S564.USD","LU0868494708.USD","LU0345768153.USD","3NVD.UK","LU2361044949.HKD","LU2462157665.USD","LU2552382132.HKD","LU2756315318.SGD","LU0494093205.USD","LU1935042991.SGD","IE00BFSS7M15.SGD","IE00B3SWFQ91.USD","LU2896262040.SGD","LU1923622291.USD","SILO","LU0203202063.USD","LU0820562030.AUD","LU2860962120.EUR","LU0965509283.SGD","LU2125909916.SGD","LU0642271901.SGD","IE000ITXATA3.USD","SGXZ99366536.SGD","LU0823421416.USD","LU2047632596.USD","LU2236285917.USD","LU2272731782.SGD","SG9999015945.SGD","LU2237443465.HKD","LU1242518857.USD","IE00BQXX3F31.USD","LU0210536198.USD","LU0683600562.USD","NVDX","LU1084165304.USD","IE0009356076.USD","IE00B4JS1V06.HKD","LU0274383776.USD","LU0289960550.SGD","LU2505996681.GBP","BK4608","NVD","BK4527","IE00BQXX3C00.GBP","LU2168564065.EUR","LU1934455277.USD","SG9999014559.SGD","LU0823421333.USD","LU1551013425.SGD","LU0820561818.USD","LU0256863811.USD","IE000YTNTUN2.SGD","LU2750360641.GBP","IE0034235188.USD","LU1261432733.SGD","LU1815336760.USD","LU2087621335.USD","NVDS.UK","LU0979878070.USD","NVDG","LU0133085943.USD","IE0004445239.USD","LU0211328371.USD","LU0347712357.USD","LU0069063385.USD","LU0310799852.SGD","LU0267386448.USD","LU0820561909.HKD","AIFD","BK4549","LU1868837136.USD","LU0070217475.USD","LU1935042215.USD","BK4533","LU0276348264.USD","LU2087625088.SGD","LU0823434583.USD","LU2265009873.SGD","HK0000819398.USD","LU0225283273.USD","LFGY","LU1127390331.HKD","NVDY","BK4554","SG9999015341.SGD","NVIW.SI","LU0354030438.USD","GB00BDT5M118.USD","LU0256863902.USD","LU1917777945.USD","LU2237957902.USD","LU2461242641.AUD","LU0210533765.USD","IE00BQXX3D17.EUR","NULC","LU0266013472.USD","SMH","LU0342679015.USD","LU0072462426.USD","LU0511384066.AUD","LU1934455194.USD","LU2491050154.USD","LU2360032135.SGD","LU2361044865.SGD","HK0000304805.HKD","IE000Q6AESB8.SGD","LU3102509885.SGD","BK4529","LU0965508806.USD","LU2237443549.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136201644","title":"Silo Pharma 开展稳健性研究，评估 SPC-15 设备性能与制剂 30 天稳定性","url":"https://stock-news.laohu8.com/highlight/detail?id=1136201644","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136201644?lang=zh_cn&edition=full","pubTime":"2026-06-30 04:18","pubTimestamp":1782764295,"startTime":"0","endTime":"0","summary":"Silo Pharma 已启动一项稳健性研究，旨在全面评估其 SPC-15 设备在长达 30 天周期内的性能表现，并同时检验相关制剂的稳定性。该研究对于验证设备与药物配方的长期可靠性与一致性至关重要。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4202","BK4139","SILO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101449389","title":"Silo Pharma公布SPC-15创伤后应激障碍治疗药物稳定性数据积极，推动项目迈向首次人体临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1101449389","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101449389?lang=zh_cn&edition=full","pubTime":"2026-06-23 20:18","pubTimestamp":1782217096,"startTime":"0","endTime":"0","summary":"Silo Pharma公司宣布，其用于治疗创伤后应激障碍的候选药物SPC-15取得了积极的稳定性研究数据。这一关键进展标志着该药物开发项目向前迈出了坚实一步，正稳步推进至首次人体临床试验阶段。稳定性数据的成功，为后续临床研究的顺利开展奠定了重要基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4202","SILO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117737017","title":"Silo Pharma旗下Demerx NB获FDA新药临床试验批准 诺伊波加因靶向酒精使用障碍治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1117737017","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117737017?lang=zh_cn&edition=full","pubTime":"2026-04-29 21:09","pubTimestamp":1777468162,"startTime":"0","endTime":"0","summary":"生物制药公司Silo Pharma Inc.宣布，其研发的Demerx NB新药已获得美国食品药品监督管理局（FDA）的新药临床试验（IND）批准。该药物以诺伊波加因（Noribogaine）为核心活性成分，旨在开发用于治疗酒精使用障碍（AUD）的新型疗法。\n此次IND获批标志着该候选药物正式获准进入人体临床研究阶段，为推进其治疗酒精依赖的潜力迈出关键一步。公司表示将按计划开展后续临床试验，以评估Demerx NB的安全性与有效性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SILO","BK4202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150576656","title":"Silo制药公司战略性收购Qwikagents平台 进军千亿美元AI代理市场","url":"https://stock-news.laohu8.com/highlight/detail?id=1150576656","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1150576656?lang=zh_cn&edition=full","pubTime":"2026-04-23 04:16","pubTimestamp":1776888982,"startTime":"0","endTime":"0","summary":"Silo制药公司宣布通过收购托管式AI代理平台Qwikagents，正式启动向价值数十亿美元的AI代理市场的战略性业务扩张。这一重大举措标志着公司从传统制药领域向人工智能技术领域的战略转型。\n此次收购将使Silo制药公司快速获得成熟的AI代理技术平台，立即进入快速增长的人工智能代理市场。Qwikagents平台作为托管式AI代理解决方案，在自动化业务流程和智能决策支持领域具有显著技术优势。\n市场分析师指出，AI代理市场预计将在未来几年呈现指数级增长，此次战略性收购为Silo制药公司提供了抢占市场先机的宝贵机会。公司表示，这一举措将有效拓展其业务范围，创造新的收入增长点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4202","SILO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516580686","title":"Silo Pharma, Inc.盘中异动 股价大跌5.46%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516580686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516580686?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:52","pubTimestamp":1741017146,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时52分，Silo Pharma, Inc.股票出现异动，股价大幅跳水5.46%。截至发稿，该股报1.28美元/股，成交量2.1069万股，换手率0.47%，振幅4.43%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235227989a244e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235227989a244e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4202","CNS","BK4135","BK4139","SILO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514438101","title":"Silo Pharma, Inc.盘中异动 股价大跌5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514438101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514438101?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:44","pubTimestamp":1740671073,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时44分，Silo Pharma, Inc.股票出现异动，股价大幅跳水5.67%。Silo Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.85%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227234433abdf8164&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227234433abdf8164&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNS","SILO","BK4139","BK4135","BK4202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514086930","title":"Silo Pharma, Inc.盘中异动 快速上涨5.40%报1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514086930","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514086930?lang=zh_cn&edition=full","pubTime":"2025-02-27 02:30","pubTimestamp":1740594617,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日02时30分，Silo Pharma, Inc.股票出现波动，股价急速拉升5.40%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022702301896317b61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022702301896317b61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4135","SILO","BK4202","CNS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514604186","title":"Silo Pharma, Inc.盘中异动 急速拉升5.56%报1.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514604186","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514604186?lang=zh_cn&edition=full","pubTime":"2025-02-26 04:58","pubTimestamp":1740517098,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日04时58分，Silo Pharma, Inc.股票出现异动，股价急速拉升5.56%。Silo Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502260458189892928d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502260458189892928d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4135","SILO","CNS","BK4202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513727576","title":"Silo Pharma, Inc.盘中异动 早盘股价大跌5.19%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513727576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513727576?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:48","pubTimestamp":1740408534,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时48分，Silo Pharma, Inc.股票出现异动，股价急速下跌5.19%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242248549890fa1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242248549890fa1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SILO","BK4135","BK4139","BK4202","CNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513153612","title":"Silo Pharma, Inc.盘中异动 下午盘急速下跌5.03%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513153612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513153612?lang=zh_cn&edition=full","pubTime":"2025-02-22 02:02","pubTimestamp":1740160928,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日02时02分，Silo Pharma, Inc.股票出现波动，股价急速跳水5.03%。Silo Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222020209962baaa3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222020209962baaa3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4135","SILO","CNS","BK4202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512806564","title":"Silo Pharma, Inc.盘中异动 快速拉升5.00%报1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512806564","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512806564?lang=zh_cn&edition=full","pubTime":"2025-02-20 01:35","pubTimestamp":1739986535,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日01时35分，Silo Pharma, Inc.股票出现波动，股价快速拉升5.00%。Silo Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200135369628eb12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200135369628eb12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4202","BK4139","BK4135","CNS","SILO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510684380","title":"Silo Pharma, Inc.盘中异动 早盘大幅下跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510684380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510684380?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:43","pubTimestamp":1739285014,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时43分，Silo Pharma, Inc.股票出现异动，股价急速下跌5.19%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为1.36%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211224334961f4a0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211224334961f4a0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SILO","BK4135","BK4139","BK4202","OCEA","CNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509272485","title":"Silo Pharma, Inc.盘中异动 早盘快速拉升5.68%报1.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509272485","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509272485?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:42","pubTimestamp":1738852920,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时42分，Silo Pharma, Inc.股票出现波动，股价快速上涨5.68%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206224201a23bd0d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206224201a23bd0d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4135","CNS","BK4139","BK4202","SILO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508572594","title":"Silo Pharma, Inc.盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508572594","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508572594?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:31","pubTimestamp":1738679489,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时31分，Silo Pharma, Inc.股票出现异动，股价大幅下挫5.02%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502042231299617d782&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502042231299617d782&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4135","CNS","BK4202","SILO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508418381","title":"Silo Pharma, Inc.盘中异动 大幅上涨11.19%报1.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508418381","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508418381?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:35","pubTimestamp":1738593321,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时35分，Silo Pharma, Inc.股票出现波动，股价大幅上涨11.19%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223521abc107f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223521abc107f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SILO","BK4135","BK4202","CNS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508696042","title":"Silo Pharma, Inc.盘中异动 大幅跳水5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508696042","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508696042?lang=zh_cn&edition=full","pubTime":"2025-02-01 00:55","pubTimestamp":1738342510,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日00时55分，Silo Pharma, Inc.股票出现异动，股价大幅跳水5.46%。Silo Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.56%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020100551098777086&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020100551098777086&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SILO","CNS","BK4139","BK4202","BK4135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506454586","title":"Silo Pharma, Inc.盘中异动 下午盘大幅下跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506454586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506454586?lang=zh_cn&edition=full","pubTime":"2025-01-28 02:39","pubTimestamp":1738003147,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日02时39分，Silo Pharma, Inc.股票出现波动，股价急速跳水5.07%。Silo Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012802390796125e17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012802390796125e17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4135","BK4202","CNS","BK4139","SILO"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.silopharma.com","stockEarnings":[{"period":"1week","weight":-0.0551},{"period":"1month","weight":-0.4794},{"period":"3month","weight":-0.5932},{"period":"6month","weight":-0.5117},{"period":"1year","weight":-0.7336},{"period":"ytd","weight":-0.5294}],"compareEarnings":[{"period":"1week","weight":0.0011},{"period":"1month","weight":0.0005},{"period":"3month","weight":0.0443},{"period":"6month","weight":0.1455},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.1294}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Silo Pharma, Inc.于2010年7月13日在纽约州注册成立。2013年1月24日，公司将其注册地从纽约州改为特拉华州。2023年12月19日，该公司将其注册州从特拉华州改为内华达州。该公司是一家处于开发阶段的生物制药和加密货币公司，专注于开发针对创伤后应激障碍、应激性焦虑症、纤维肌痛和中枢神经系统疾病等未满足需求的新型疗法。其主要项目SPC-15是一种用于治疗创伤后应激障碍和应激性焦虑症的鼻内候选药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.152367},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.066329},{"month":3,"riseRate":0.333333,"avgChangeRate":0.008428},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.080378},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.077056},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.06968},{"month":7,"riseRate":0.666667,"avgChangeRate":0.150388},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.191166},{"month":9,"riseRate":0.5,"avgChangeRate":6.713866},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.161821},{"month":11,"riseRate":0.333333,"avgChangeRate":0.075379},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.093022}],"exchange":"NASDAQ","name":"SILO PHARMA INC.","nameEN":"SILO PHARMA INC."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SILO PHARMA INC.(SILO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供SILO PHARMA INC.(SILO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"SILO PHARMA INC.,SILO,SILO PHARMA INC.股票,SILO PHARMA INC.股票老虎,SILO PHARMA INC.股票老虎国际,SILO PHARMA INC.行情,SILO PHARMA INC.股票行情,SILO PHARMA INC.股价,SILO PHARMA INC.股市,SILO PHARMA INC.股票价格,SILO PHARMA INC.股票交易,SILO PHARMA INC.股票购买,SILO PHARMA INC.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SILO PHARMA INC.(SILO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供SILO PHARMA INC.(SILO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}